JCO
Nuveen Credit Opportunities 2022 Target Term Fund
Set alert
7.95 0.00 0.00%
7.94 Day range 7.96
7.95 52-week range 7.96
- Open
- 7.94
- Prev close
- 7.95
- Mkt cap
- 220.81M
- Vol
- 38.34K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.94
- High
- 7.96
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 7.95
- 200-d avg
- 7.95
Key statistics
- Market cap
- 220.81M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 7.95
- 200-day average
- 7.95
Next earnings
Consensus EPS estimate 0.00.
News
- RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited
- Daily Journal Corp. (S.C.) (NASDAQ:DJCO) and American Community Newspapers (OTCMKTS:ACNI) Critical Review
- Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
- Innovent Announces Taletrectinib（ROS1 Inhibitor）Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting
- Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting
- New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer
- Nuveen Credit Opportunities 2022 Target Term Fund Announces Termination and Liquidation
- Nuveen Credit Opportunities 2022 Target Term Fund Declares Special Distribution
- Stocks That Hit 52-Week Lows On Tuesday
- Nuveen Credit Opportunities 2022 Target Term Fund Announces Liquidation Details
Your note
Sign in to keep a note on JCO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| MEYERS WILLIAM T. | Officer | Purchase | Oct 14, 2018 | 722 |
| NUVEEN FUND ADVISORS, L.L.C. | Investment Advisor | Sale | Jan 11, 2021 | 0 |